Axillary Hyperhidrosis
📧 Sign up to get email alerts when something new happens for Axillary Hyperhidrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Comparison of the Clinical Efficacy and Adverse Reactions of Different Needling Patterns of High-frequency Microneedles in the Treatment of Axillary Odor [NA]
This completed clinical trial compares the clinical efficacy and adverse reactions of different needling patterns of high-frequency micronee…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Miradry Treatment for Focal Axillary Hyperhidrosis [NA]
Clinical trial update indicates the miraDry treatment for focal axillary hyperhidrosis has been terminated, with results posted on 2025-05-3…
-
CLINICAL_TRIALS withdrawal · 2024-12-24Clinical Trial Update: Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis [Phase 2]
Phase 2 trial comparing 1% GPB Cream with Qbrexza glycopyrronium cloth for Primary Axillary Hyperhidrosis has been withdrawn.
-
FDA approval · 2024-06-18FDA Approved: SOFDRA — Original Application (Botanix SB Inc.)
The FDA approved SOFDRA (sofpironium bromide) from Botanix SB Inc. through an original NDA for the treatment of primary axillary hyperhidros…
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301) [Phase 3]
Phase 3 safety and efficacy study of Sofpironium bromide in axillary hyperhidrosis has completed, with results posted in 2024. The trial ide…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302) [Phase 3]
Phase 3 safety and efficacy study of Sofpironium bromide for axillary hyperhidrosis has completed and results were posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis [Phase 2]
Phase 2 clinical trial evaluating the safety, tolerability, systemic exposure, and efficacy of GPB Cream in adolescents with primary axillar…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating [NA]
Clinical trial update for the N-SWEAT Patch evaluating treatment of primary axillary hyperhidrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis [Phase 3]
Phase 3 safety study of BBI-4000 Gel in patients with primary axillary hyperhidrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis. [Phase 3]
Phase 3 clinical trial update evaluating efficacy and safety of 1% glycopyrronium bromide topical cream for primary axillary hyperhidrosis, …
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis [Phase 2]
Phase 2 safety study of BBI-4000 Gel in pediatric patients with primary axillary hyperhidrosis has completed.
-
FDA approval · 2022-10-28FDA Approved: QBREXZA — Supplemental Application (Journey Medical Corporation)
The FDA approved a supplemental application for QBREXZA (glycopyrronium) filed by Journey Medical Corporation. This action updates the produ…
-
FDA approval · 2020-07-20FDA Approved: QBREXZA — Supplemental Application (Journey Medical Corporation)
The FDA approved a supplemental application for QBREXZA (glycopyrronium) submitted by Journey Medical Corporation.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis [NA]
A completed clinical trial evaluating the Ulthera System for treating axillary hyperhidrosis has posted results.
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis [Phase 2]
Phase 2 comparator trial evaluating the effects of glycopyrrolate vs glycopyrronium in subjects with axillary hyperhidrosis, with results po…
-
FDA approval · 2018-06-28FDA Approved: QBREXZA — Original Application (Journey Medical Corporation)
FDA approved QBREXZA (glycopyrronium) from Journey Medical Corporation as an original NDA for the topical treatment of primary axillary hype…
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis [NA]
This is an update on a completed clinical trial evaluating fractional micro-needle radiofrequency and botulinum toxin A for primary axillary…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of a botulinum toxin type A topical gel for primary axillary hyperhidrosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Unicentric Comparing Study of Suction Curettage With Standard BOTOX Injection in the Treatment of Patients With Essential Axillar Hyperhidrosis: Comparing of Efficacy, Duration of Effectiveness, and Adverse Events. [Phase 4]
A Phase 4 unicentric trial comparing suction curettage with standard Botox injections for essential axillary hyperhidrosis has been terminat…
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Tx Axillary Hyperhidrosis 1210nm Diode Laser [NA]
This clinical trial update concerns axillary hyperhidrosis treated with a 1210 nm diode laser at the United States Naval Medical Center in S…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Clinical Evaluation of the miraDry System in Subjects With Hyperhidrosis [NA]
A clinical evaluation of the miraDry System for treating axillary hyperhidrosis has completed enrollment and assessment in study participant…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis) [NA]
A completed clinical trial investigating Botox with suction-curettage for axillary hyperhidrosis, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis [Phase 2]
A Phase 2 clinical trial evaluating ANT-1403 for primary axillary hyperhidrosis has completed.
-
CLINICAL_TRIALS trial_result · 2010-05-06Clinical Trial Update: Use of Oxybutynin to Treat Axillary Hyperhidrosis [NA]
This entry reports a completed trial evaluating oxybutynin for axillary hyperhidrosis and osmidrosis. The sponsor is Grupo de Cirurgia Vascu…
-
CLINICAL_TRIALS trial_result · 2008-09-19Clinical Trial Update: VASER Treatment of Axillary Hyperhidrosis/Bromidrosis [Phase 4]
Phase 4 clinical trial update for VASER ultrasonic treatment of axillary hyperhidrosis and bromhidrosis; the study has completed.